Status
Conditions
Treatments
About
This study aims to evaluate the impact of an intelligent care system on radiation therapy patients, focusing on real-time blood data monitoring, optimized patient education, and internal alert systems. The goal is to enhance patient safety, improve treatment adherence, and reduce anxiety by integrating an alert function into the hospital's existing system.
Key interventions include:
Real-time blood monitoring alerts: Healthcare providers will receive automatic notifications of abnormal blood test results to ensure timely intervention.
Optimized patient education materials: Clearer guidance will help patients proactively communicate blood test needs and manage their health during radiation therapy.
Internal reminders: Visual signs and alerts in treatment areas will reinforce patient awareness and engagement.
The study will compare patients receiving these interventions with those under standard care, assessing treatment compliance, anxiety levels, and clinical outcomes over a 12-month period.
Full description
Background & Rationale Cancer patients undergoing radiation therapy often experience changes in blood cell counts, particularly when combined with chemotherapy, affecting treatment safety and completion rates. Lack of real-time monitoring and patient engagement can lead to delays or complications in treatment. This study integrates an intelligent care system into clinical practice to enhance patient monitoring and education, reducing treatment interruptions and improving outcomes.
Study Objectives
System Optimization: Develop an automated blood data monitoring system that alerts medical staff and patients about abnormal results.
Patient Education Enhancement: Improve educational materials to guide patients on self-care and timely communication with healthcare providers.
Internal Warning Implementation: Install reminder signs in treatment areas to increase awareness and compliance.
Study Design
Type: Interventional (Clinical Trial) Design: Randomized, parallel assignment
Groups:
Intervention Group: Receives real-time monitoring alerts, enhanced education materials, and internal warning systems.
Control Group: Receives standard care without system enhancements. Primary Outcomes: Anxiety reduction (measured by BSRS-5) and treatment adherence rates.
Secondary Outcomes: Blood data changes, patient understanding of self-care, and clinical treatment outcomes.
Expected Impact By combining real-time data monitoring with patient education and engagement, this study aims to create a safer, more informed treatment experience, reducing patient anxiety and enhancing overall treatment success.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
100 participants in 2 patient groups
Loading...
Central trial contact
Yueh-Chun Lee, MD-PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal